Nintedanib is an antifibrotic medicine used to slow progressive scarring of the lungs in certain interstitial lung diseases. It cannot reverse existing lung damage, but it may help slow further loss of lung function and delay disease progression.
| Generic Name | Nintedanib |
| Strength | 150 mg |
| Manufacturer | Cipla |
| Packing | 30 Capsules |
| Prescribed For | Treat chronic fibrosing (scarring) lung diseases |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Nintedanib blocks several tyrosine kinase enzymes involved in the development of fibrous lung tissue. This reduces the activity of cells responsible for lung scarring. It does not reverse existing damage, but it can help slow further decline in lung function.